FI20021545A0 - Lignankomplex - Google Patents

Lignankomplex

Info

Publication number
FI20021545A0
FI20021545A0 FI20021545A FI20021545A FI20021545A0 FI 20021545 A0 FI20021545 A0 FI 20021545A0 FI 20021545 A FI20021545 A FI 20021545A FI 20021545 A FI20021545 A FI 20021545A FI 20021545 A0 FI20021545 A0 FI 20021545A0
Authority
FI
Finland
Prior art keywords
lignan
lignankomplex
complex
cyclodextrin
disclosed
Prior art date
Application number
FI20021545A
Other languages
English (en)
Finnish (fi)
Other versions
FI114917B (sv
FI20021545A (sv
Inventor
Tomi Jaervinen
Pekka Jarho
Mikko Unkila
Mervi Hiilovaara-Teijo
Original Assignee
Hormos Nutraceutical Oy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Nutraceutical Oy Ltd filed Critical Hormos Nutraceutical Oy Ltd
Publication of FI20021545A0 publication Critical patent/FI20021545A0/sv
Priority to FI20021545A priority Critical patent/FI114917B/sv
Priority to ES03735732T priority patent/ES2310663T3/es
Priority to DK03735732T priority patent/DK1554316T3/da
Priority to DE60322244T priority patent/DE60322244D1/de
Priority to AT03735732T priority patent/ATE401351T1/de
Priority to US10/521,761 priority patent/US20050249857A1/en
Priority to EP03735732A priority patent/EP1554316B1/en
Priority to AU2003238106A priority patent/AU2003238106A1/en
Priority to PCT/FI2003/000511 priority patent/WO2004020474A1/en
Publication of FI20021545A publication Critical patent/FI20021545A/sv
Application granted granted Critical
Publication of FI114917B publication Critical patent/FI114917B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI20021545A 2002-08-29 2002-08-29 Lignankomplex FI114917B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20021545A FI114917B (sv) 2002-08-29 2002-08-29 Lignankomplex
AT03735732T ATE401351T1 (de) 2002-08-29 2003-06-24 Lignankomplexe
DK03735732T DK1554316T3 (da) 2002-08-29 2003-06-24 Inklusionskompleks af en lignan
DE60322244T DE60322244D1 (de) 2002-08-29 2003-06-24 Lignankomplexe
ES03735732T ES2310663T3 (es) 2002-08-29 2003-06-24 Compuestos de lignanos.
US10/521,761 US20050249857A1 (en) 2002-08-29 2003-06-24 Lignan complexes
EP03735732A EP1554316B1 (en) 2002-08-29 2003-06-24 Lignan complexes
AU2003238106A AU2003238106A1 (en) 2002-08-29 2003-06-24 Lignan complexes
PCT/FI2003/000511 WO2004020474A1 (en) 2002-08-29 2003-06-24 Lignan complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20021545 2002-08-29
FI20021545A FI114917B (sv) 2002-08-29 2002-08-29 Lignankomplex

Publications (3)

Publication Number Publication Date
FI20021545A0 true FI20021545A0 (sv) 2002-08-29
FI20021545A FI20021545A (sv) 2004-03-01
FI114917B FI114917B (sv) 2005-01-31

Family

ID=8564494

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021545A FI114917B (sv) 2002-08-29 2002-08-29 Lignankomplex

Country Status (9)

Country Link
US (1) US20050249857A1 (sv)
EP (1) EP1554316B1 (sv)
AT (1) ATE401351T1 (sv)
AU (1) AU2003238106A1 (sv)
DE (1) DE60322244D1 (sv)
DK (1) DK1554316T3 (sv)
ES (1) ES2310663T3 (sv)
FI (1) FI114917B (sv)
WO (1) WO2004020474A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396783C (zh) * 2006-03-07 2008-06-25 谭兴起 络石藤的木脂素苷元总提取物的提取工艺方法及其产品
EP2517574B1 (de) * 2011-04-29 2015-11-11 Symrise AG Bestimmte Vanillyllignane und deren Verwendung als Geschmacksverbesserer
JP7079931B2 (ja) * 2018-05-10 2022-06-03 淳三 亀井 セサミノールとシクロデキストリンとの包接複合体及びその製造方法
KR102143405B1 (ko) 2018-11-16 2020-08-11 한국화학연구원 리그난 포접물 및 이의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上5▼―不飽和化酵素阻害剤
ATE208195T1 (de) * 1989-07-21 2001-11-15 Suntory Ltd Mittel zur verbesserung der leberfunktion
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6451849B1 (en) * 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
US6689809B2 (en) * 1999-03-30 2004-02-10 Hormos Nutraceutical Oy Ltd. Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
BR0116850A (pt) * 2001-01-31 2004-02-25 Pfizer Prod Inc Derivados de amida de ácido tiazolil-, oxazolil-, pirrolil- e imidazolil- úteis como inibidores de isoenzimas de pde4
FI20021184A (sv) * 2002-06-19 2003-12-20 Hormos Nutraceutical Oy Ltd Lignanpreparat

Also Published As

Publication number Publication date
DE60322244D1 (de) 2008-08-28
ATE401351T1 (de) 2008-08-15
ES2310663T3 (es) 2009-01-16
WO2004020474A1 (en) 2004-03-11
US20050249857A1 (en) 2005-11-10
EP1554316B1 (en) 2008-07-16
DK1554316T3 (da) 2008-11-17
FI114917B (sv) 2005-01-31
AU2003238106A1 (en) 2004-03-19
FI20021545A (sv) 2004-03-01
EP1554316A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
BRPI0412254A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
LUC00065I2 (sv)
AR048181A1 (es) Composicion de ingredientes funcionales
BRPI0510364A (pt) detecção e tipagem de cepas bacterianas
NO20084337L (no) Cartenoid-inneholdende kost supplement
EP2218342A3 (en) Novel nutraceutical compositions and use thereof
AU2003290387A1 (en) Dietry supplements and foods product comprising oleylethanolamide
AU2003205710A1 (en) Use of anti-adhesive packaging materials for packaging chemicals and food
DE60322244D1 (de) Lignankomplexe
PT1292570E (pt) Sal de creatina que possui uma eficacia nutricional e terapeutica melhorada e composicoes que o contem
DE50000168D1 (de) Orale darreichungsform
FI20021822A0 (sv) Livsmedel
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
DE602007007784D1 (de) Präbiotikumhaltiges flüssiges nahrungsmittelprodukt
ITMI20021366A1 (it) Composizioni nutraceutiche e integratori alimentari contenenti nadh
ATE464896T1 (de) Zubereitung enthaltend oxidierte flavonoid- derivate
UA46475S (uk) 1. розгортка опаковання для дієтичної добавки
UA46474S (uk) 1. розгортка опаковання для дієтичної добавки
UA45832S (uk) 1. розгортка опаковання для дієтичної добавки
WO2004002953A3 (fr) Composes lactones, utilisables en tant qu'agents antioxydants dans des compositions pharmaceutiques, cosmetiques ou alimentaires
UA45292S (uk) 1. розгортка опаковання для дієтичної добавки
ITMI20000197A0 (it) Procedimento per la produzione di componenti per integratori alimentari formulazioni dietetiche cosmetiche e farmaceutiche derivati da semi
BRPI0403459A (pt) formulações alimentìcias preparadas a partir de farelo de cìtricos
UA40050A (uk) Харчова композиція
EP2272503A3 (en) Oral formulations of cladribine

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114917

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: HORMOS MEDICAL LTD.

Free format text: HORMOS MEDICAL LTD.

MM Patent lapsed